Market Cap (In KRW)
670.02 Billion
Revenue (In KRW)
859.62 Billion
Net Income (In KRW)
40.2 Billion
Avg. Volume
121.94 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9180.0-13750.0
- PE
- -
- EPS
- -
- Beta Value
- 0.599
- ISIN
- KR7003850005
- CUSIP
- -
- CIK
- -
- Shares
- 83962910.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jay Kim
- Employee Count
- -
- Website
- https://www.boryung.co.kr
- Ipo Date
- 2000-01-04
- Details
- Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.
More Stocks
-
NICLPT PAM Mineral Tbk
NICL
-
OCDOOcado Group plc
OCDO
-
RETINARetina Paints Limited
RETINA
-
9556
-
SECI
-
CVGR
-
EGMMF
-
GEOS